Workshop on 

Digital Health Technologies for a World Free of TB

July 24th – 26th 2018

New Delhi, India

Get App for the Workshop

The United States Government (USG) is committed to supporting the development of an inclusive, responsible, and sustainable global digital ecosystem. The United State Agency for International Development (USAID) promotes the application of the digital development principles, a set of best practices in active projects as well as activities under the Center for Digital Development. Digital technologies strengthen health systems at multiple levels by improving data services and information flow for system managers and offering health providers and patients better access to innovative tools in prevention, diagnosis and treatment for TB and DRTB.

Our Speakers

Dr V S Salhotra

Dr Virender Singh Salhotra is the Additional Deputy Director General (TB) at the Central TB Division in the Ministry of Health and Family Welfare, Government of India. Dr. Salhotra has a post graduate qualification in public health from Lady Hardinge Medical College. He has been working for Tuberculosis for more than 15 years and carries tremendous experience in TB Control Programme implementation.

He has also served on international platform for 5 years in SAARC TB & HIV/AIDS Centre, Kathmandu, Nepal. Currently, he is looking after the important portfolio of implementation of programme management activities for Drug Resistant TB, Procurement & Supply Chain Management, and donor coordination including World Bank loan & Global Fund grant implementation. He is the person responsible at the national level for driving the introduction of Bedaquiline and shorter regimen for drug resistant TB in the country. He has also initiated phased implementation of Universal DST in the country.

Dr. K S Sachdeva

Dr Sachdeva is a public health physician, presently working as Deputy Director General at Central TB Division. He had worked in the program earlier for a period of 8 years looking after multiple portfolios including Drug Resistant TB, Laboratory, TB-Comorbidity etc. Prior to the present position, he worked in National AIDS Control Organization overseeing HIV counseling & testing services, STI, TB-HIV collaborative activities, research and Global Fund activities implementation.

He has also served as the Chief District Medical Officer, South Zone, for the Govt of NCT, Delhi and a Nodal Officer for the National Rural Health Mission as well as Chief Medical Officer for the Essential Drugs Program within the Directorate of Health Services, Govt of NCT, Delhi. As Chief Medical Officer for the Essential Drugs Program, Dr Sachdeva was in charge of the central procurement agency and essential drug program. This included developing an Essential Drugs List and Quality Assurance mechanism of drugs and surgical consumables. He was also the resource person for capacity building in rational use of drugs, procurement, and logistics management.

Dr Sachdeva obtained his MBBS degree from the Maulana Azad Medical College, University of Delhi and has additional training in TB & chest diseases from the VP Chest Institute at the University Of Delhi.

Dr. Giorgio Roscigno

Dr. Roscigno is a senior public health specialist with broad pharma and diagnostics l experience in the private as well as the public sector.
He has 18 years experience in a Research based MNC ( Aventis Sanofi) and 13 years experience in the Public Private Mix having contributed to the creation and lead  of 3 major Product Development Partnership: The Global Alliance ( CEO 2000 -2003)  FIND ( CEO 2003-2011) and The African Society for Laboratory Medicine (COO 2012-2013).
Dr. Roscigno is currently since 2013 leading a New organization called NEXT2PEOPLE (Geneva, Pretoria): a paradigm shift with a great focus on exploring innovative roles for the private sector in Public Health for Emerging Economies.

As founder and first Chief Executive Officer at FIND ( Geneva) in 2003, has overseen the development of 5 new WHO-approved diagnostic tools for Tuberculosis, the distribution and implementation of these tools in 27 High Burden Countries ( among these the Genexpert broadly considered the first revolutionary tool in TB Diagnosis). He was also among the founding members and first  CEO of the Global Alliance for TB Drug Development ( New York /Brussels), a non-profit public-private partnership dedicated to TB drug discovery.

Roscigno spent 18 years in a research based Pharmaceutical Company. He has served as Medical Director for Africa, Asia, and Europe (Merrel Dow), the European Clinical Research Director for Anti-infectives ( Marion Merrel Dow); and finally the International Medical Director for Anti-infectives with Aventis in Paris, France.
Roscigno has contributed significantly, inspired and led the clinical work of all TB fixed-dose combinations containing rifampicin, the development of rifapentine ( TB) and DFMO eflornithine ( sleeping sickness) up to their FDA approvals.

Dr. Suresh Kunhi Mohammed

Dr. Suresh K. Mohammed is working as Senior Health Specialist in the World Bank with the Global Practice on Health, Nutrition and Population since 2016. Prior to joining the Bank,  Dr. Mohammed worked in various positions with the Indian Federal Ministry of Health and Family Welfare in New Delhi and with the Government of Karnataka in Bangalore. He also worked in the India Country office of the World Health Organization in New Delhi as National Consultant for the AIDS Control Program. Dr. Mohammed has an MPH from the Rollins School of Public Health- Emory University, a Post Graduate Diploma in Management and Public Policy from the Indian Institute of Management Bangalore and is a Doctor of Medicine (MBBS) from Calicut Medical College.

Dr Kirankumar Rade

Dr Rade is associated with the WHO Country Office for India as a Medical Consultant since 2005. He played a crucial role in establishing DOTS services and capacity building for quality assurance and TB-HIV coordination in the State of Bihar during his assignment from 2005-2008 followed by a successful stint in Gujarat from July 2008 to March 2011, where he was instrumental in establishing STDC Ahmedabad as a national training center for drug resistant TB, validation of newer diagnostic technologies and also designing a state representative TB prevalence survey, the only of its kind in India. Government of Gujarat recognized his contribution with special award.

While working as National Consultant TB Epidemiologist, he designed online case-based application named Nikshay, which received National eGovernance Gold Award by Ministry of Information Technology, Government of India. He also played a vital role in making TB notification mandatory and developing tools and mechanisms for comprehensive TB surveillance in India. Dr Rade also contributed in review of India’s EHR/EMR policies as well as MDDS at high level in Ministry of Health & Family Welfare, designing strategies for India’s National Strategic Plan 2012-17 and recent TB Elimination Plan 2017-2025.

Dr. Devesh Gupta

Since 2007, Dr Devesh Gupta has been associated with Revised National TB Control Programme of Government of India. Dr Gupta has over 36 years of experience with Central Health Services. At Central TB Division, he led several HIV-TB care interventions. He directed the development of Standards for TB Care in India which torched the pathway of reviving partnership with private health care provider.

In 2017, Dr Devesh guided path breaking change in treatment of drug sensitive TB from intermittent to daily regimen across the country. Under his leadership, Information Technology enabled interventions expanded multiple folds. NIKSHAY has been enhanced with linkages of PFMS, IT enabled adherence.

Recently, Direct Benefit Transfer has been launched under RNTCP which is once again led by Dr Devesh led the path once again. The DBT schemes under RNTCP is an effort of efficient, transparent system of financial transaction and increasing accountability of Government.

Kaiser Shen

Kaiser Shen serves as the Tuberculosis Lab and Diagnostic Network Advisor. In this role, Kaiser aims to strengthen and improve TB laboratory and diagnostic network capacity, including oversight of digital health activities. He also supports PEPFAR-funded USAID TB laboratory activities through monitoring and advising USAID partners on laboratory interventions.

Previously, Kaiser served as a Senior Specialist for the Association of Public Health Laboratories, managing PEPFAR-related laboratory systems strengthening activities in Angola, Mozambique, Zambia and South Africa. He was previously at USAID serving as a Global Health Fellows Program Intern with the Tuberculosis Team focused on GeneXpert implementation. Kaiser has worked in the academic arena with biomedical research experience in immunology, microbiology and vaccine development. Kaiser holds a Master of Public Health from John Hopkins Bloomberg School of Public Health and a Master of Science in Microbiology from the University of Michigan.

Marc D Porter

Marc D Porter is a faculty member in the University of Utah’s (UofU) Chemistry and Chemical Engineering departments. His research interests are in analytical chemistry, interfacial science, and nanotechnology. He is also the Director of the Nano Institute of Utah, which integrates researchers across Utah and the surrounding region into core research focus areas to address emerging “big science” questions in human health and energy. His laboratory has a long standing interest in sandwich immunoassay development and validation work using Surface-enhanced Raman Scattering (SERS) detection and giant magnetoresistance (GMR), to name a few. For over 10 years Porter also led a joint research team with personnel from NASA’s Johnson Space Center and Wyle Laboratories, a major contractor with NASA. The goal of this project was to design, construct, carry out an Earth-bound development and then microgravity flight simulations and performance assessments on a much needed water quality analyzer for eventual deployment as permanent hardware on the International Space Station (ISS). He has also co-founded several companies.

 

Jennifer Harnisch Granger

Jennifer Harnisch Granger obtained her MS in Organic Chemistry in 1998 and PhD in Analytical Chemistry in 2001 from Iowa State University. After graduation, she spent three years as a research scientist in R&D and marketing at Waters Corporation.  In this capacity, she authored six patents and launched four new products to support liquid chromatography and mass spectrometry in the life sciences. She then accepted a position as team leader for the LCMS analytical group at AstraZeneca Pharmaceuticals where she was responsible for managing and maintaining open-access site instrumentation used by over 100 chemists. In 2007 she returned to academia and joined the Nano Institute of Utah at the University of Utah as a Research Associate. Her current research is dedicated to the development of new detection strategies for pathogens, diseases, and biowarfare agents.

Dr. Anant Bhan

Anant Bhan is trained as a medical doctor with a masters’ degree in bioethics from the University of Toronto. He is a researcher in the fields of Global Health, Health Policy and Bioethics. He is an Adjunct Visiting Professor in the Centre for Ethics, Yenepoya University, Mangaluru, India. In the past, he has worked for NGOs and a government public health training institution in India, as well as a consultant to a project on Ethical, Social and Cultural issues in health biotechnology based at the University of Toronto, and as Senior Manager with the International AIDS Vaccine Initiative in their India Regional Office. Anant has published extensively in various national and international medical journals in the field of global/public health and bioethics, as well as contributed to popular mass media. He is on the Editorial Board of ‘Public Health Ethics’ (www.phe.oxfordjournals.org), a quarterly journal of Oxford University Press and also serves on the International Advisory Board of the Asian Bioethics Review (http://www.asianbioethicsreview.com). He is also a member of the Ethics Working Group of the US NIH‐funded HIV Prevention Trials Network (http://www.hptn.org/hptnresearchethics.htm).

Anant has been a resource person for trainings in global health, research methodology, research ethics and public health ethics, and also serves as guest faculty in various educational institutions in India and abroad. He has been as a reviewer for multiple journals, conference scientific committees and international grant competitions. Anant was a member of the Working Group set up to revise the 2002 CIOMS International Ethical Guidelines for Biomedical Research involving Humans, and a sub-committee involved in revising the 2006 ICMR Ethical Guidelines for Biomedical Research on Human Subjects. He serves on the Steering Committee of the Global Forum on Bioethics in Research, and is the President of the International Association of Bioethics.

Ali Habib

Ali has been CEO of Interactive Health Solutions (IHS) since 2013 He is a strong proponent of open source software and ICT4D, he has led the assessment, design development, and deployment of open source mobile data collection, and web-based electronic medical record systems for TB control projects and programs in Pakistan, Tajikistan, Nepal, Bangladesh, Indonesia, Timor Leste, Papua New Guinea, South Africa, DRC, Kenya, Uganda, Zimbabwe, Ethiopia, Malawi, Brazil, and Peru. Ali works closely with open source communities like OpenMRS and OpenSRP to help use technology to address gaps in health delivery in resource limited settings. Ali has been part of the technology leadership teams for the Zero TB Karachi Initiative; endTB, a USD 60 million UNITAID grant to introduce new TB drugs for patients with XDR-TB and complicated MDR-TB, and OpenSRP, an open source initiative to empower front line health workers using mobile technology.

Mukesh Sadana

Mukesh Sadana is a Digital Development Advisor and Financial Inclusion Specialist with USAID/India. He has over 17 years of work experience in rural development and has worked in sales & marketing, banking, and consulting. Mukesh has worked in Bangladesh, India, Kenya, Indonesia, the Philippines, Nepal, Vietnam, Malawi, and Papua New Guinea on a wide variety of assignments supporting government agencies, central banks, private sector, and service providers in these countries.

Mukesh is currently working on identifying and integrating digital technologies that can help development programs reach out to target populations in efficient, user friendly and cost effective ways. He is also managing a project that aims to increase use of digital payments among low-income populations and small merchants. An incubator set up under the project is supporting five start-ups with different business models focusing on a wide variety of use cases.

Mukesh has earlier worked with ICICI Bank- the largest private sector bank in India, and Gujarat Cooperative Milk Marketing Federation Ltd. (AMUL)- the largest milk and milk products marketing federation in India. Before joining USAID, Mukesh worked with MicroSave, a technical assistance provider and think tank.

He holds a Post Graduate Diploma in Rural Management from the Institute of Rural Management in Anand (IRMA), India.

Dr. Peter Barron

Dr. Peter Barron is a Public health specialist, with 35 years experience of improving the quality of care at primary care level and implementation of a district health system in South Africa. Has a special interest in management of routine information and monitoring and evaluation and more recently mHealth; currently gives oversight to a national mHealth programme for pregnant women (MomConnect) in South Africa.

Worked as a rural district hospital doctor in what is now Namibia and the Eastern Cape and Mpumalanga provinces of South Africa; senior health manager in local government health services in Cape Town; acting head of the newly formed health department in the Northern Cape Province (after democracy in 1994); senior manager at Health Systems Trust for 14 years(a large independent NGO); freelance consultant in public health in many countries in Africa and Indian sub-continent (mostly as team leader); for the past 8 years has been a long term consultant in the national Department of Health of South Africa giving support around information systems, HIV, TB and maternal and child health.

Was a member of the technical review panel (TRP) of The Global Fund for Rounds 2007 to 2010 and participated in several country audits (as the public health expert) of the office of the Inspector-General of The Global Fund.

Is the author of over 50 peer-reviewed journal articles; as well as many publications in grey literature; conceptualised and wrote the District Health Barometer of the Health Systems Trust and has been an editor of the South African Health Review on many occasions.

Dr. Richard Lester

Dr. Richard Lester is the Director of the Neglected Global Diseases Initiative (NGDI) and an Associate Professor in Global Health in the Division of Infectious Diseases, Department of Medicine, at the University of British Columbia. He completed his research fellowship in HIV in Kenya at the University of Manitoba and University of Nairobi collaborative, where he initiated development of an innovative mobile phone health (mHealth) service that was demonstrated in a landmark trial, WelTel Kenya1 (Lancet 2010), to improve HIV outcomes. He is Scientific and Executive Director of the WelTel International mHealth Society, a non-profit organization and Grand Challenges Canada $1M award winner for transitioning the mHealth service to scale in remote Kenya. Dr. Lester also conducted a trial for LTBI in Canada and member of the WHO Task Force for Digital Health in TB Control.  His program’s ‘research to action’ and patient self-management approach has been published in top-tier medical journals, including the Lancet, the New England Journal of Medicine, and Nature, and has been featured in non-academic international and local media, such as CBC’s The National and The Economist. Dr. Lester continues to conduct studies internationally, in Kenya, Canada, and the United States, has consulted on mHealth innovations with the World Health Organization, and is a CIHR Foundation Scheme recipient and Michael Smith Foundation for Health Research Scholar.

Neeraj Kak

Neeraj Kak is URC’s Chief Innovation Officer and Senior Vice President of URC’s Center for Innovations and Technology (CIT) since 2011, and for nine years prior to that as the division’s Vice President. His visionary leadership and technical and administrative oversight supported the development of original, technology-driven tools and approaches towards advances in public health. CIT’s work is currently focused primarily in the Middle East, Central and Southeast Asia, and southern Africa.

Neeraj is a creative and innovative health management specialist with extensive technical experience in HIV/AIDS and TB programs. He has more than 25 years of experience guiding health managers in Africa and Asia to develop national and operational strategies to improve access to and demand for health programs addressing HIV/AIDS and family planning and reproductive health.

Hala Jassim AlMossawi

Dr. Hala Jassim AlMossawi, BDS, MSc, MSHCA is a public health specialist with over twenty (20) years of experience in professional development, project management, capacity building, quality improvement and monitoring and evaluation. She currently works at University Research Co., LLC (URC) as a Senior Director of Technical Support providing technical backstop to various projects in Asia, Middle East, South East Asia, Europe, Southern Africa. She serves as a Corporate Monitor of USAID Albania Transparency in Health Engagement Project, USAID TB Platforms for Sustainable Detection, Care and Treatment in the Philippines and MCC funded Reduce Impaired Child Growth & Development/Stunting for Timor-Leste Compact Development project. Dr. AlMossawi is the Activity Manager of the global USAID TB CARE II project. She has served as a Technical and Training Lead for the DTRA-funded CBEP project in Iraq and Afghanistan as well as Vietnam. She has also served as a Chief of Party for the USAID-funded Primary Health Care Project in Iraq (PHCPI) 2011-2015.

Gopi Gopalakrishnan

Gopi Gopalakrishnan has three decades of experience in implementing large-scale service-delivery programs in low-resource settings. He has founded two large organizations—World Health Partners which focuses on delivering primary health care to rural communities by innovatively harnessing existing resources in the poorest states of India and Kenya; Janani which delivers reproductive health services in Bihar and Jharkhand, two of the poorest states of India.

Gopi’s network management strategies have been recognized worldwide as some of the most effective ways for translating the vast unmet need of underserved communities into adoption with a focus on the ‘here and now’. A major part of Gopi’s work relates to operationalizing public–private partnerships in which private sector resources are tailored to complement public sector service provision. Increasingly, his recent work has devoted attention to integrate stronger management systems and technologies into public sector programming.

He has been a member of India’s Population Commission and has advised the Ministry of Health and Family Welfare and numerous national and international organizations on large-scale cost-effective service delivery. He has served on the global technical advisory board of the International Finance Corporation, an affiliate of the World Bank, and is currently a member of the Advisory Group on Community Action (AGCA) of the National Health Mission.

During his career, Mr. Gopalakrishnan also worked as the Director of International Programs of DKT International based in Washington DC and as Country Director of DKT Vietnam based in Hanoi. He has been awarded by the Skoll Foundation, the Schwab (World Economic Forum) Foundation and Ashoka Foundation for social entrepreneurship and is also recipient of a prestigious civilian honor from the Government of Vietnam.

Beth Ann Lopez

Beth Ann Lopez is Director of Public Affairs at mClinica. She built and led a team to launch mClinica’s mobile application SwipeRx in Vietnam, which is now mClinica’s fastest-growing market. She previously led mClinica’s expansion to Cambodia. Prior to joining mClinica, she worked in international development in Southeast Asia for five years. She consulted on the impact evaluation of a $57m USAID childhood nutrition project, wrote policy recommendations for the Royal Thai government to improve a migrant health insurance scheme, and served in the Peace Corps in Cambodia from 2012 to 2014. She has an MPH in Health Policy from the Harvard T.H. Chan School of Public Health.

Dr. Sanjay Sarin

Dr. Sanjay Sarin is currently the Country Head, India and lead for Access Program (Asia Pacific) at Foundation for Innovative New Diagnostics (FIND) where he is responsible for leading operational and administrative management of in-country activities, representing FIND to local and international stakeholders and providing leadership and strategic direction to FIND’s development and access teams and projects in Asia. At FIND, he is a member of the organization’s leadership team.

Prior to that, Sanjay has held multiple roles in Becton Dickinson, a global medical device and diagnostic company. As the Regional Director, Global Health for BD in Asia Pacific he was responsible for design, development, and implementation of BD’s public health and partnership strategies towards accomplishment of company’s overall strategic goals through an extensive network of external partners and stakeholders from the government, non-profit, donors, and UN agencies. During his stint with BD, he also served as the Business Director of the Preanalytical Systems business vertical for BD in India and South Asia. Sanjay was a member of the BD’s Country leadership team and the Worldwide Extended Leadership team.
He has previously been an entrepreneur, served as a Senior Manager with the Apollo Hospitals followed by a stint as Regional Lab Advisor (India & South East Asia) with Clinton Health Access Initiative.

Sanjay has close to 20 years of experience in health policy, market development, and business management with specialization in the development of strategic initiatives for driving growth in emerging markets.

Kristian van Kalmthout

Kristian van Kalmthout is a Digital Health Consultant at KNCV Tuberculosis Foundation. In 2011 he graduated Maastricht University with a master degree in Global Health and wrote his thesis on how to leverage internet and mobile phones to improve volunteer coordination and disaster response in Kenya. He gained work experience in the use of information and communication technology (ICT) in various settings such as health programs, hospitals, and internet companies.

In 2015, he joined KNCV as Young Professional and was given the opportunity to develop a broad professional basis in TB control through intensive training in The Hague coupled with an international field assessment of 2,5 months in Bangladesh.

As part of the Digital Health Solutions team, he currently supports the implementation of digital health solutions in focus countries and help to create pathways for acceleration of applying digital health in projects and programs. His main areas of interest and expertise are in the use of TB diagnostic connectivity solutions and digital treatment adherence technologies. Kristian van Kalmthout is a member of the WHO Global Task Force on digital health for TB and the Global Laboratory Initiative (GLI) Diagnostic Connectivity Task Force.

Sabyasachi Das

Sabyasachi is currently the Head of Business Development at Dure Technologies, where he is responsible for implementing digital solutions in the public health space and leads engagement initiatives with high-profile partners like the UN, the Ministry of Health, donors and NGOs across the globe. In addition, Sabyasachi has extensive experience in designing and implementing digital innovations in the public health sphere, particularly in the TB domain. During his previous stint with the Government of India, as part of the State e-Governance Mission Team, he was instrumental in implementing India’s largest Mobile Governance project. He has also worked as an AVP, Digital Innovations at IFMR Trust and as a Portion Manager at Villgro Innovation Foundation. Sabyasachi is a Molecular Biologist by education and has worked as a Research Fellow at All India Institute of Medical Sciences (AIIMS), Delhi.

CK Cheruvettolil

As the Senior Manager for the Innovative Technology Solutions Team at the Gates Foundation, CK provides strategic business advice to program teams, reviews investments and provide financial analysis and support to the program teams. He also works closely with the program staff to identify and fund innovative technology solutions for global health. Prior to joining the Gates Foundation, CK was a consultant to the Centers for Disease Control and helped design the architecture and implementation of their public health tracking network which integrated environmental and health data across federal and state agencies. CK has a Masters in Economics from Duke University and is passionate about data and data visualization.

Kenneth W. Goodman

Kenneth W. Goodman, PhD, FACMI, is founder and director of the University of Miami Miller School of Medicine’s Institute for Bioethics and Health Policy.  He is a Professor of Medicine and jointly of Philosophy.  His research has emphasized issues in health information technology and in epidemiology and public health. His latest book, Ethics, Medicine, and Information Technology: Intelligent Machines and the Transformation of Health Care (Cambridge University Press 2016) identifies and analyzes a number of issues in biomedical informatics.

Dr. Dennis Falzon

Dr Dennis Falzon is a medical officer with the Global TB Programme of the World Health Organization (WHO) in Geneva, Switzerland. Until 2008 he coordinated the EuroTB surveillance project in Paris, France, and before that he worked in TB and drug-resistant TB surveillance and programme management with Médecins sans Frontières in Central Asia. His current work at WHO focuses on the development of policy guidance for the management of drug-resistant tuberculosis, monitoring and evaluation in TB control, country support and the integration of digital technologies in the implementation of the End TB Strategy.

Alexander Golubkov

Alexander Golubkov, MD, MPH, currently serves as the Senior Tuberculosis Advisor (MDR-TB) at the USAID Global Health Bureau, Office of Infectious Diseases, TB Division. In this role, Dr. Golubkov provides technical leadership and coordination in the field of MDR-TB. He coordinates implementation of the National Action Plan for Combating MDR-TB and advises on tasks related to DR-TB global activities. He also provides technical TB backstop to a number of USAID-priority countries. Prior to joining USAID, Dr. Golubkov served as a Medical Director for Russia and Kazakhstan for Partners In Health (PIH), a non-profit international public health NGO based in Boston, Massachusetts.

A N M Al Imran

With a 10+ year working experience International Development, currently working with URC as eHealth Specialist. Previously worked for TB CARE II Bangladesh funded by USAID, where Imran provided technical support to National Tuberculosis Control Programme (NTP) Bangladesh to designed and implement a mobile application (TB mHealth) to monitor daily treatment and to manage Adverse Drug Reactions of DR TB patients under community based treatment and Xpert reporting system to send GeneXpert lab reports to the referring laboratories and SMS notification to the suspected MDR TB patients. Currently Imran is supporting TB South Africa project in developing and managing various eTools to monitor TB patients under community based treatment, health education and for project monitoring and evaluation.

Workshop Brief

On July 24-26, 2018, USAID TB CARE II project organized a global workshop on “Digital Health Technologies for a World Free of Tuberculosis” in New Delhi, India. USAID TB CARE II team organized this workshop jointly with USAID/India Mission and India India’s Ministry of Health and Family Welfare. The workshop was attended by 151 participants (57% male; 43% female) from countries across the globe, including 8 of the 10 NAP countries, including India, Indonesia, Kazakhstan, Myanmar, Pakistan (remotely), Philippines, South Africa, and Ukraine. The workshop was joined by over 40 participants from private sector, 50 participants from other implementing partners and international organizations and 8 from the academia. The workshop was also joined by participants from digital technology developers, digital health experts and entrepreneurs from the US, Canada, Europe, India and the region.

This workshop included representation from NAP country national TB programs, USAID/W and India, the World Health Organization, the World Bank, Bill and Melinda Gates Foundation (based in US and India) the CDC, and USAID. Private tech companies and implementing organizations also participated. Dignitaries and high level officials from the US Embassy to India as well as the Government of India’s Ministry of Health and Family Welfare joined for panel discussions, country presentations, and technology demonstrations throughout the workshop.

Send Us a Message

If you have any questions about the event, please contact us.







back to top